INMB
INmune Bio Inc.
$1.51
+$0.02(+1.34%)
35
Overall
60
Value
10
Tech
--
Quality
Market Cap
$41.21M
Volume
296.76K
52W Range
$1.38 - $11.64
Target Price
$12.67
EPS Estimates Overview
| Current Quarter | $-0.28 | Next Quarter | $NA |
| Current Year | $-1.23 | Next Year | $-1.29 |
| QoQ Growth | NaN% | YoY Growth | -4.9% |
| 3Y EPS CAGR | -3.9% | Target Price | $12.67 |
| Consensus | Buy | Upside | +739.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INMB | $1.51 | +1.3% | 296.76K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |